A family that runs an established group of companies across multiple industries actively makes direct investments into life science companies in Seed to Series A rounds, and sometimes Series B. Initial average check sizes are between $500k – 1M, though the firm has invested up to $2M. The firm does occasionally participate in pre-IPO rounds with larger commitments, but this has been in companies outside of the life sciences industry. In addition, the group is an LP in some micro-VCs that invest in various sectors, and works with them to identify promising co-investment opportunities. The firm has mainly considered opportunities in USA and Western Europe, but is open to all companies across the globe with the exception of India, as the group already has a strong network there.
Within life sciences, the firm is most interested in medical device companies and has looked into surgical devices, robotics, etc. The firm is open to all regulatory pathways, but prefers 510k companies. Current areas of interest include elderly care/longevity, genetics, and microbiome. The firm will not consider therapeutics or in vitro diagnostics companies; digital health may be considered but is not a high priority.
The firm has no specific company or management team requirements and usually acts as a co-investor. The firm has a strong hospital network as part of their business, and they actively help with the due diligence process.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 